Update on leukotriene, lipoxin and oxoeicosanoid receptors: IUPHAR Review 7

Bäck, Magnus, Powell, William S, Dahlén, Sven‐Erik, Drazen, Jeffrey M, Evans, Jilly F, Serhan, Charles N, Shimizu, Takao, Yokomizo, Takehiko +1 more·2014·British Journal of Pharmacology

Cited by (217)

Items 101–200 of 217

  1. Fatty acid binding protein 4/aP2-dependent BLT1R expression and signaling
    Ann Vogel Hertzel, Hongliang Xu, Michael C. Downey, Nicholas Kvalheim, David Bernlohr · 2017 · Journal of Lipid Research
  2. Chemical Tools for Studying Lipid-Binding Class A G Protein–Coupled Receptors
    Anna G. Cooper, Sameek Singh, Sarah M. Hook, Joel D. A. Tyndall, Andrea J. Vernall · 2017 · Pharmacological Reviews
  3. Atopic Patients Show Increased Interleukin 4 Plasma Levels but the Degree of Elevation Is Not Sufficient to Upregulate Interleukin-4-Sensitive Genes
    Eugenia Marbach-Breitrück, Andrea Kalledat, Dagmar Heydeck, Sabine Stehling, Joachim W. Fluhr, Torsten Zuberbier, Hartmut Kühn · 2019 · Skin Pharmacology and Physiology
  4. Intrathecal administration of Resolvin D1 and E1 decreases hyperalgesia in mice with bone cancer pain: Involvement of endocannabinoid signaling
    Iryna A. Khasabova, Mikhail Y. Golovko, Svetlana A. Golovko, Donald A. Simone, Sergey G. Khasabov · 2020 · Prostaglandins & Other Lipid Mediators
  5. Activated immune response in an inherited leukodystrophy disease caused by the loss of oligodendrocyte gap junctions
    Sameh K. Wasseff, Steven S. Scherer · 2015 · Neurobiology of Disease
  6. Pituitary Adenoma and the Chemokine Network: A Systemic View
    Fabio Grizzi, Elena Monica Borroni, Alessandro Vacchini, Dorina Qehajaj, Manuela Liguori, Sanja Štifter, Maurizio Chiriva‐Internati, Antonio Di Ieva · 2015 · Frontiers in Endocrinology
  7. Targeting the OXE receptor as a potential novel therapy for asthma
    William S. Powell, Joshua Rokach · 2020 · Biochemical Pharmacology
  8. Montelukast Use Decreases Cardiovascular Events in Asthmatics
    Malvina Hoxha, Calogero C. Tedesco, Silvana Quaglini, Висар Малај, Linda Pustina, Valérie Capra, Jilly F. Evans, Angelo Sala, G. Enrico Rovati · 2021 · Frontiers in Pharmacology
  9. Lipoxin alleviates oxidative stress: a state-of-the-art review
    You Zhou, Chongge You · 2022 · Inflammation Research
  10. Anti-allergy activities of Kuji amber extract and kujigamberol
    Miku Maruyama, Miki Kobayashi, Takeshi Uchida, Eisaku Shimizu, Hironori Higashio, Misa Ohno, Shota Uesugi, Ken‐ichi Kimura · 2018 · Fitoterapia
  11. Neuromodulatory effects of leukotriene receptor antagonists: A comprehensive review
    Radhika Sood, Shailendra Anoopkumar‐Dukie, Santosh Rudrawar, Susan Hall · 2024 · European Journal of Pharmacology
  12. Montelukast Inhibits Platelet Activation Induced by Plasma From COVID-19 Patients
    Marina Camera, Paola Canzano, Marta Brambilla, G. Enrico Rovati · 2022 · Frontiers in Pharmacology
  13. Montelukast Ameliorates Scopolamine-induced Alzheimer’s Disease: Role on Cholinergic Neurotransmission, Antioxidant Defence System, Neuroinflammation and Expression of BDNF
    Bhavana Yerraguravagari, Naga Pavani Penchikala, Aravinda Sai Kolusu, Grandhi Sandeep Ganesh, Prasad Konduri, Kumar V.S. Nemmani, Pavan Kumar Samudrala · 2023 · CNS & Neurological Disorders - Drug Targets
  14. Neuroprotective Effects of Lipoxin A4 in Central Nervous System Pathologies
    Alessandra Cadete Martini, Stefânia Forner, Allisson Freire Bento, Giles Alexander Rae · 2014 · BioMed Research International
  15. Role of Cysteinyl Leukotrienes in Allergic Rhinitis
    Hideaki Shirasaki, Tetsuo Himi · 2016 · Advances in oto-rhino-laryngology
  16. BLT1 signalling protects the liver against acetaminophen hepatotoxicity by preventing excessive accumulation of hepatic neutrophils
    Ken Kojo, Yoshiya Ito, Koji Eshima, Nobuyuki Nishizawa, Hirotoki Ohkubo, Takehiko Yokomizo, Takao Shimizu, Masahiko Watanabe, Masataka Majima · 2016 · Scientific Reports
  17. Type 1 reaction in leprosy patients corresponds with a decrease in pro-resolving and an increase in pro-inflammatory lipid mediators
    Carlos A. M. Silva, Kristofor J. Webb, Barbara G. Andre, Maria Angela M. Marques, Fernanda Marques de Carvalho, Cristiana Santos de Macedo, Roberta Olmo Pinheiro, Euzenir Nunes Sarno, María Cristina Vidal Pessolani, John T. Belisle · 2016 · The Journal of Infectious Diseases
  18. Cysteinyl-leukotriene pathway as a new therapeutic target for the treatment of atherosclerosis related to obstructive sleep apnea syndrome
    Elodie Gautier‐Veyret, Magnus Bäck, Claire Arnaud, Elise Belaïdi, Renaud Tamisier, Patrick A. Levy, Nathalie Arnol, Marion Perrin, Jean‐Louis Pépin, Françoise Stanke‐Labesque · 2018 · Pharmacological Research
  19. Modulation of leukotriene signaling inhibiting cell growth in chronic myeloid leukemia
    Elham Yektaei‐Karin, Ana Zovko, Anders Nilsson, Barbro Näsman‐Glaser, Lena Kanter, Olof Rådmark, Jonas Wallvik, Marja Ekblom, Monika Dolinska, Hong Qian et al. · 2016 · Leukemia & lymphoma/Leukemia and lymphoma
  20. Biosynthesis and actions of 5-oxoeicosatetraenoic acid (5-oxo-ETE) on feline granulocytes
    Chantal Cossette, Sylvie Gravel, Chintam Nagendra Reddy, Vivek Gore, Shishir Chourey, Qiuji Ye, Nathaniel W. Snyder, Clementina Mesaros, Ian A. Blair, Jean‐Pierre Lavoie et al. · 2015 · Biochemical Pharmacology
  21. Superconserved Receptors Expressed in the Brain: Expression, Function, Motifs and Evolution of an Orphan Receptor Family
    Claudia Stäubert, Monika Woźniak, Nadine Dupuis, Céline Laschet, Thanigaimalai Pillaiyar, Julien Hanson · 2022 · Pharmacology & Therapeutics
  22. Cytosolic phospholipase A2 contributes to innate immune defense against Candida albicans lung infection
    Sabarirajan Jayaraja, Azzeddine Dakhama, Bogeon Yun, Moumita Ghosh, Hee-Jung Lee, Elizabeth F. Redente, Charis L. Uhlson, Robert C. Murphy, Christina C. Leslie · 2016 · BMC Immunology
  23. Roles of Lipoxygenases in Cardiovascular Diseases
    Ting Liu, Ding Ai · 2025 · Journal of Cardiovascular Translational Research
  24. Specialized proresolution mediators in the bladder: annexin-A1 normalizes inflammation and bladder dysfunction during bladder outlet obstruction
    Francis M. Hughes, Shelby N. Harper, Brent D. Nosé, Armand Allkanjari, Michael Zheng, Huixia Jin, J. Todd Purves · 2021 · American Journal of Physiology-Renal Physiology
  25. Effects of inflammation in dental pulp cell differentiation and reparative response
    Francine Lorencetti‐Silva, Larissa Sthefani Sales, Giuliana de Campos Chaves Lamarque, Giovana Amorim Caixeta, Maya Fernanda Manfrin Arnez, Lúcia Helena Faccioli, Francisco Wanderley Garcia Paula‐Silva · 2022 · Frontiers in Dental Medicine
  26. Lipoxins and their relationship with inflammation-associated diseases. A systematic review
    Maria Fernanda Serna-Orozco, Mildrey Mosquera, Herney Andrés García‐Perdomo · 2023 · Obesity Research & Clinical Practice
  27. Signaling by neutrophil G protein-coupled receptors that regulate the release of superoxide anions
    Cláes Dahlgren, Huamei Fu Forsman, Martina Sundqvist, Lena I Björkman, Jonas Mårtensson · 2024 · Journal of Leukocyte Biology
  28. Differential regulation of monocytic expression of leukotriene and lipoxin receptors
    Marcelo H. Petri, Silke Thul, О. А. Овчинникова, Magnus Bäck · 2015 · Prostaglandins & Other Lipid Mediators
  29. Structural diversity of leukotriene G-protein coupled receptors
    Aleksandra P. Luginina, Anastasiia Gusach, Elizaveta Lyapina, Polina A. Khorn, Nadezhda A. Safronova, Mikhail B. Shevtsov, Daria A. Dmitrieva, Dmitrii E. Dashevskii, Tatiana Kotova, Ekaterina Smirnova et al. · 2023 · Journal of Biological Chemistry
  30. Basic Mechanisms of Atherosclerosis
    Magnus Bäck, Göran K. Hansson · 2017 · Elsevier eBooks
  31. Role of Translocator 18 KDa Ligands in the Activation of Leukotriene B4 Activated G-Protein Coupled Receptor and Toll Like Receptor-4 Pathways in Neutrophils
    Léonard de Vinci Kanda Kupa, Carine Cristiane Drewes, Éric Diego Barioni, Camila Lima Neves, Sandra Coccuzzo Sampaio, Sandra Helena Poliselli Farsky · 2017 · Frontiers in Pharmacology
  32. Class A Orphans (version 2019.5) in the IUPHAR/BPS Guide to Pharmacology Database
    S P H Alexander, Jim Battey, Helen E. Benson, Richard V. Benya, Tom I. Bonner, Anthony P. Davenport, Satoru Eguchi, Anthony J. Harmar, Nicholas D. Holliday, Robert T. Jensen et al. · 2019 · IUPHAR/BPS Guide to Pharmacology CITE
  33. Specialized pro-resolution mediators in the bladder: Receptor expression and recovery of bladder function from cystitis
    Francis M. Hughes, Armand Allkanjari, Michael R. Odom, Huixia Jin, J. Todd Purves · 2022 · Experimental Biology and Medicine
  34. Cysteinyl-maresin 3 inhibits IL-13 induced airway hyperresponsiveness through alternative activation of the CysLT1 receptor
    Jesper Säfholm, Willem Abma, Lora Georgieva Bankova, Joshua A. Boyce, Mamdoh Al‐Ameri, Ann‐Charlotte Orre, Craig Edward Wheelock, Sven‐Erik Dahlén, Mikael Adner A · 2022 · European Journal of Pharmacology
  35. Effects of Montelukast on Neuroinflammation in Parkinson's Disease: An Open Label Safety and Tolerability Trial with CSF Markers and [ 11C ] PBR28 PET
    Johan Wallin, Anton Forsberg, Per Svenningsson · 2025 · Movement Disorders
  36. Targeting the OXE receptor with a selective antagonist inhibits allergen‐induced pulmonary inflammation in non‐human primates
    Chantal Cossette, Lisa A. Miller, Qiuji Ye, Shishir Chourey, Chintam Nagendra Reddy, Joshua Rokach, William S. Powell · 2021 · British Journal of Pharmacology
  37. The complex role of eicosanoids in the brain: Implications for brain tumor development and therapeutic opportunities
    Hsien-Chung Chen, Wen‐Chang Chang, Jian‐Ying Chuang, Kwang‐Yu Chang, Jing‐Ping Liou, Tsung‐I Hsu · 2023 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  38. Expression and localization of GPR99 in human nasal mucosa
    Hideaki Shirasaki, Etsukó Kanaizumi, Tetsuo Himi · 2016 · Auris Nasus Larynx
  39. Novel highly potent OXE receptor antagonists with prolonged plasma lifetimes that are converted to active metabolites in vivo in monkeys
    Qiuji Ye, Shishir Chourey, Chintam Nagendra Reddy, Rui Wang, Chantal Cossette, Sylvie Gravel, Irina Slobodchikova, Dajana Vuckovic, Joshua Rokach, William S. Powell · 2019 · British Journal of Pharmacology
  40. Identification of cysteinyl-leukotriene-receptor 1 antagonists as ligands for the bile acid receptor GPBAR1
    Michele Biagioli, Adriana Carino, Silvia Marchianò, Rosalinda Roselli, Cristina Di Giorgio, Martina Bordoni, Chiara Fiorucci, Valentina Sepe, Paolo Conflitti, Vittorio Limongelli et al. · 2020 · Biochemical Pharmacology
  41. Prostaglandins, Leukotrienes, and Related Compounds
    Robert B. Zurier · 2016 · Elsevier eBooks
  42. Resolvin D1 attenuates Ang II-induced hypertension in mice by inhibiting the proliferation, migration and phenotypic transformation of vascular smooth muscle cells by blocking the RhoA/mitogen-activated protein kinase pathway
    Wei Cheng, Jishou Zhang, Shanshan Peng, Jianfang Liu, Yao Qun Xu, Mengmeng Zhao, Shuwan Xu, Wei Dong Pan, Zheng Yin, Zihui Zheng et al. · 2023 · Journal of Hypertension
  43. The role of the 12(S)-HETE/GPR31/12-HETER axis in cancer and ischemia–reperfusion injury
    Monica Napolitano · 2019 · Biochemical Society Transactions
  44. Pleiotropic antifibrotic actions of aspirin-triggered resolvin D1 in the lungs
    Rafael F. Guilherme, José Bruno Nunes Ferreira Silva, Ingrid Waclawiak, Vanderlei da Silva Fraga‐Junior, Thaís Oliveira Cassiano dos Santos Nogueira, Cyntia Pecli e Silva, Carlla Assis Araújo-Silva, Nathalia Santos Magalhães, Felipe S. Lemos, Carlos A. Bulant et al. · 2023 · Frontiers in Immunology
  45. Research progress in the mechanisms and functions of specialized pro-resolving mediators in neurological diseases
    Yu Deng, Fei Wang, Tianle Wang, Xu Zhang, Du Chen, Yuhan Wang, Chaojun Chen, Guangtao Pan · 2024 · Prostaglandins & Other Lipid Mediators
  46. Leukotriene B4 receptor 2 correlates with prognosis and immune infiltration in clear cell renal cell carcinoma
    Xia Yuan, Yi He, Chen‐Hui Luo, Wei Wang · 2021 · Investigational New Drugs
  47. Development of synthetic lipoxin-A4 mimetics (sLXms): New avenues in the treatment of cardio-metabolic diseases
    Monica de Gaetano · 2022 · Seminars in Immunology
  48. Inhibition of allergen‐induced dermal eosinophilia by an oxoeicosanoid receptor antagonist in non‐human primates
    Lisa A. Miller, Chantal Cossette, Shishir Chourey, Qiuji Ye, Chintam Nagendra Reddy, Joshua Rokach, William S. Powell · 2019 · British Journal of Pharmacology
  49. Reprogramming of arachidonic acid metabolism using α-terpineol to alleviate asthma: insights from metabolomics
    Ying Rong, Fanglin Liu, Hui Hua Zhou, Tong Yu, Zhaolong Qin, Qianwen Cao, Luyao Liu, Xiaoge Ma, Lingbo Qu, Peirong Xu et al. · 2024 · Food & Function
  50. Modulation of lipid mediator profile may contribute to amelioration of chronic inflammation in adipose tissue of obese mice by pioglitazone
    Kumiko Okada, Tetsuya Hosooka, Masakazu Shinohara, Wataru Ogawa · 2018 · Biochemical and Biophysical Research Communications
  51. Class A Orphans (version 2020.5) in the IUPHAR/BPS Guide to Pharmacology Database
    S P H Alexander, Jim Battey, Helen E. Benson, Richard V. Benya, Tom I. Bonner, Anthony P. Davenport, Khuraijam Dhanachandra Singh, Satoru Eguchi, Anthony J. Harmar, Nicholas D. Holliday et al. · 2020 · IUPHAR/BPS Guide to Pharmacology CITE
  52. STIM Proteins and Orai Ca2+ Channels Are Involved in the Intracellular Pathways Activated by TLQP-21 in RAW264.7 Macrophages
    Laura Molteni, Laura Rizzi, Elena Bresciani, Ramona Meanti, Jean‐Alain Fehrentz, Pascal Verdié, Robert J. Omeljaniuk, Giuseppe Biagini, Vittorio Locatelli, Antonio Torsello · 2018 · Frontiers in Pharmacology
  53. Emerging role of cysteinyl LTs in cancer
    Lou Saier, Olivier Peyruchaud · 2021 · British Journal of Pharmacology
  54. New insights on pharmacological potential of montelukast: a comprehensive review
    Karan Goel, Dhirendra Singh, Rajat Goyal, Seema Bansal, Sukhbir Singh, Neelam Sharma, Sumeet Gupta · 2025 · Inflammopharmacology
  55. Aspirin‑induced asthma: a still evolving area of basic and clinical research
    Marek Sanak · 2022 · Polskie Archiwum Medycyny Wewnętrznej
  56. Metabolism and pharmacokinetics of a potent N-acylindole antagonist of the OXE receptor for the eosinophil chemoattractant 5-oxo-6,8,11,14-eicosatetraenoic acid (5-oxo-ETE) in rats and monkeys
    Chintam Nagendra Reddy, Alhamza Hussam W, Shishir Chourey, Qiuji Ye, Vivek Gore, Chantal Cossette, Sylvie Gravel, Irina Slobodchikova, Dajana Vuckovic, Joshua Rokach et al. · 2018 · European Journal of Pharmaceutical Sciences
  57. LTB4 is converted into a potent human neutrophil NADPH oxidase activator via a receptor transactivation mechanism in which the BLT1 receptor activates the free fatty acid receptor 2
    Yan‐Ling Wu, Cláes Dahlgren, Huamei Fu Forsman, Martina Sundqvist · 2025 · Prostaglandins Leukotrienes and Essential Fatty Acids
  58. Montelukast suppresses the development of irritable bowel syndrome phenotype possibly through modulating NF-κB signaling in an experimental model
    Pariya Khodabakhsh, Nilgoon Khoie, Ahmad Reza Dehpour, Alireza Abdollahi, Mahmoud Ghazi-Khansari, Hamed Shafaroodi · 2022 · Inflammopharmacology
  59. Class A Orphans in GtoPdb v.2023.1
    S P H Alexander, Jim Battey, Helen E. Benson, Richard V. Benya, Tom I. Bonner, Anthony P. Davenport, Khuraijam Dhanachandra Singh, Satoru Eguchi, Anthony J. Harmar, Nicholas D. Holliday et al. · 2023 · IUPHAR/BPS Guide to Pharmacology CITE
  60. Anti-Inflammatory and Pro-Resolving Actions of the N-Terminal Peptides Ac2-26, Ac2-12, and Ac9-25 of Annexin A1 on Conjunctival Goblet Cell Function
    Anne V. Lyngstadaas, Markus V. Olsen, Jeffrey A. Bair, Menglu Yang, Robin R. Hodges, Tor Paaske Utheim, Charles Nicholas Serhan, Darlene Ann Dartt · 2023 · American Journal Of Pathology
  61. Selective Display of a Chemoattractant Agonist on Cancer Cells Activates the Formyl Peptide Receptor 1 on Immune Cells**
    Eden L. Sikorski, Janessa Wehr, Noel J. Ferraro, Sophia Rizzo, Marcos M. Pires, Damien Thévenin · 2022 · ChemBioChem
  62. Impact of Selected Eicosanoids in Normal and Pathological Pregnancies
    Małgorzata Szczuko, Justyna Golańska, Joanna Palma, Maciej Ziętek · 2023 · Journal of Clinical Medicine
  63. The leukotriene receptor antagonist montelukast as a potential therapeutic adjuvant in multiple sclerosis – a review
    Frank Pietrantonio, A. N. SERREQI, Horst Zerbe, Per Svenningsson, Ludwig Aigner · 2024 · Frontiers in Pharmacology
  64. Portal Hypertension in NASH: Is It Different from Other Aetiologies?
    Sven Francque, Wilhelmus Josephus Kwanten, Denise van der Graaff · 2019 · Current Hepatology Reports
  65. GPCRs in innate and adaptive immune responses
    George Dubyak · 2019 · Elsevier eBooks
  66. Synthesis of Enantiopure 6,11‐Methylene Lipoxin B4 Methyl Ester
    Lukas Trippe, Analuisa Nava, Andrea Frank, U. Nubbemeyer · 2021 · European Journal of Organic Chemistry
  67. Effect of alpha lipoic acid on leukotriene A 4 hydrolase
    María José Torres, Angélica Fierro, Carlos David Pessoa-Mahana, Javier Romero‐Parra, Gonzalo Cabrera, Mario Faúndez · 2017 · European Journal of Pharmacology
  68. Lipid Mediators in Inflammation
    Shuh Narumiya, Takehiko Yokomizo, Junken Aoki · 2017 · Wiley-VCH eBooks
  69. [Doping: health risks and relation to addictive behaviors].
    Françoise Siri, Bernard Pierre Roques · 2003 · PubMed
  70. Exploiting the 2-(1,3,4,9-tetrahydropyrano[3,4- b ]indol-1-yl)acetic Acid Scaffold to Generate COXTRANs: A New Class of Dual Cyclooxygenase Inhibitors-Thromboxane Receptor Antagonists
    Federica Blua, Francesca Boccato, Carola Buccellati, Patrizia Risé, Silvia Stella Barbieri, Laura Castiglioni, Annika Balzulat, Barbara Rolando, Elisabetta Marini, Marta Balestra et al. · 2025 · Journal of Medicinal Chemistry
  71. A personal journey with bioactive lipids
    Yusuf Awni Hannun · 2015 · European Journal of Lipid Science and Technology
  72. 5-Oxo-ETE and Inflammation
    William S. Powell, Joshua Rokach · 2016 · Springer eBooks
  73. Visualization of ligand‐induced G i ‐protein activation in chemotaxing cells
    Kazuyuki Masuda, Jun-Ichi Kitakami, Tohru Kozasa, Tatsuhiko Kodama, Sigeo Ihara, Takao Hamakubo · 2016 · The FASEB Journal
  74. Pro-resolving Mediators
    William Antônio Gonçalves, Alesandra Côrte Reis Melão, Mauro Martins Teixeira, Bárbara Maximino Rezende, Vanessa Pinho · 2018 · Springer eBooks
  75. Can Bisphenols Alter the Inflammation Process?
    Denis Bažány, Hana Greifová, Lucia Zuščíková, Katarína Tokárová, Tomáš Jambor, Anton Kováčik, Norbert Lukáč · 2025 · Life
  76. Leukotriene receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database
    Magnus Bäck, Charles Brink, Nan Chiang, Sven‐Erik Dahlén, Gordon Dent, Jeffrey M. Drazen, Jilly F. Evans, Douglas W.P. Hay, Motonao Nakamura, William S. Powell et al. · 2019 · IUPHAR/BPS Guide to Pharmacology CITE
  77. Class A Orphans in GtoPdb v.2021.3
    S P H Alexander, Jim Battey, Helen E. Benson, Richard V. Benya, Tom I. Bonner, Anthony P. Davenport, Khuraijam Dhanachandra Singh, Satoru Eguchi, Anthony J. Harmar, Nicholas D. Holliday et al. · 2021 · IUPHAR/BPS Guide to Pharmacology CITE
  78. Lack of effects of Resolvin D1 after spinal cord injury in mice
    Isaac Francos-Quijorna, Nestor López-González, Marc Caro-Canton, Alba Sánchez‐Fernández, Gerard Hernández-Mir, Rubén López‐Vales · 2025 · Experimental Neurology
  79. Leukotrienes as Biomarkers of Cardiovascular Disease
    Magnus Bäck, Carlos Labat, Françoise Stanke‐Labesque, Athanase Bénétos · 2016 · Springer eBooks
  80. Arterial Stiffness and Blood Pressure during the Aging Process
    Athanase Bénétos, Magnus Bäck, Michel E. Safar, Harold Smulyan · 2019 · Cambridge University Press eBooks
  81. Bioactive lipids and cancer metastasis to bone
    Lou Saier, Hira Niazi, Leyre Brizuela, Bodo Levkau, Olivier Peyruchaud · 2021 · Journal of Cancer Metastasis and Treatment
  82. G protein-coupled receptors and inflammation resolution signaling networks in the heart: Pharmacology and potential for innovative therapeutics
    Deanna K. Sosnowski, Terence E. Hébert, Dobromir Dobrev, Stanley Nattel · 2026 · Pharmacological Reviews
  83. The Changing Face of Atherosclerosis
    Anna Meiliana, Andi Wijaya · 2023 · The Indonesian Biomedical Journal
  84. Lipoxygenases and Cardiovascular Diseases
    Andrés Laguna-Fernández, Marcelo H. Petri, Silke Thul, Magnus Bäck · 2016 · Springer eBooks
  85. Cellular Assays for Evaluating Calcium-Dependent Translocation of cPLA2α to Membrane
    Bogeon Yun, Christina C. Leslie · 2016 · Methods in enzymology on CD-ROM/Methods in enzymology
  86. Anti-leukotriene drugs in the therapy of inflammatory diseases
    Bartłomiej Pyrak, Karolina Rogacka, Dariusz Maciej Pisklak · 2022 · Prospects in Pharmaceutical Sciences
  87. Hepato-protective effects of Montelukast against methotrexate-induced hepatotoxicity in rat model
    2023 · Journal of Population Therapeutics and Clinical Pharmacology
  88. Leukotriene receptors (version 2020.3) in the IUPHAR/BPS Guide to Pharmacology Database
    Magnus Bäck, Charles Brink, Nan Chiang, Sven‐Erik Dahlén, Gordon Dent, Jeffrey M. Drazen, Jilly F. Evans, Douglas W.P. Hay, Motonao Nakamura, William S. Powell et al. · 2020 · IUPHAR/BPS Guide to Pharmacology CITE
  89. Class A Orphans (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database
    S P H Alexander, Jim Battey, Helen E. Benson, Richard V. Benya, Tom I. Bonner, Anthony P. Davenport, Satoru Eguchi, Anthony J. Harmar, Nicholas D. Holliday, Robert T. Jensen et al. · 2019 · IUPHAR/BPS Guide to Pharmacology CITE
  90. Leukotrienes as Biomarkers of Cardiovascular Disease
    Magnus Bäck, Carlos Labat, Françoise Stanke‐Labesque, Athanase Bénétos · 2015 · Springer eBooks
  91. Class A Orphans in GtoPdb v.2022.3
    S P H Alexander, Jim Battey, Helen E. Benson, Richard V. Benya, Tom I. Bonner, Anthony P. Davenport, Khuraijam Dhanachandra Singh, Satoru Eguchi, Anthony J. Harmar, Nicholas D. Holliday et al. · 2022 · IUPHAR/BPS Guide to Pharmacology CITE
  92. Insights into 5-Lipoxygenase Active Site and Catalysis
    Sunayana Mitra · 2015
  93. Assessment and mechanism of the refractory period in asthma
    Andrew Ruddick · 2015 · Leicester Research Archive (University of Leicester)
  94. The structural basis for the catalytic specificity of manganese lipoxygenases : 3D structure analysis of the lipoxygenase of Magnaporthe oryzae
    Anneli Wennman · 2015 · KTH Publication Database DiVA (KTH Royal Institute of Technology)
  95. The role of FPR2/ALX in the vascular wall
    Marcelo H. Petri · 2015 · Figshare
  96. Avaliação da expressão gênica de células da polpa dentária após estimulação com microesferas contendo mediadores lipídicos
    Francine Lorencetti da Silva · 2017
  97. The Homeostatic Factor Del-1 Promotes Periodontal Bone Regeneration During Resolution of Periodontitis
    Da‐Yo Yuh · 2019 · ScholarlyCommons (University of Pennsylvania)
  98. ApoE-Knockout Mice: What are New Achievements of this Model of Atherosclerosis?
    Barbara Lorkowska-Zawicka, Jacek Jawień · 2021 · Acta Scientific Pharmaceutical Sciences
  99. Contribution of bioactive lipid mediators in neuroinflammation, resolution, and neuroprotection
    A. A. Farooqui · 2021 · Elsevier eBooks
  100. Pro-resolving Mediators
    Hildur H. Arnardottir, Magnus Bäck · 2021 · Springer eBooks